Description
FUNDING SIGNAL (medium): Immitra Bio
Round: Pre-Seed
Estimate: 3-8 hires expected
Immitra Bio, a Zürich-based genetic medicine platform bringing scalability and commercial viability to gene editing therapies, has announced the completion of an upsized €2.58 million (CHF 2.4 million) pre-Seed financing round. Venture capital and private investors contributed €2.42 million (CHF 2.25 million), while an additional €161.8k (CHF 150k) was obtained through non-dilutive funding sources. The […] The post Zürich-based Immitra Bio secures €2.58 million to scale its scalable in-vivo genetic medicine platform appeared first on EU-Startups .
Employer contacts (email/phone/telegram) are hidden from the public preview —
send your CV, and we will connect you directly.